| Literature DB >> 31162005 |
Nusrat Najnin1,2, Karin Leder1, Andrew Forbes1, Leanne Unicomb2, Firdausi Qadri2, Pavani K Ram3, Peter J Winch4, Farzana Begum2, Shwapon Biswas5,2, Tahmina Parvin2, Farzana Yeasmin2, Alejandro Cravioto6,2, Stephen P Luby7,2.
Abstract
To explore the consistency in impact evaluation based on reported diarrhea, we compared diarrhea data collected through two different surveys and with observed diarrhea-associated hospitalization for children aged ≤ 5 years from a non-blinded cluster-randomized trial conducted over 2 years in urban Dhaka. We have previously reported that the interventions did not reduce diarrhea-associated hospitalization for children aged ≤ 5 years in this trial. We randomly allocated 90 geographic clusters comprising > 60,000 low-income households into three groups: cholera vaccine only, vaccine plus behavior change (cholera vaccine and handwashing plus drinking water chlorination promotion), and control. We calculated reported diarrhea prevalence within the last 2 days using data collected from two different survey methods. The "census" data were collected from each household every 6 months for updating household demographic information. The "monthly survey" data were collected every month from a subset of randomly selected study households for monitoring the uptake of behavior change interventions. We used binomial regression with a logarithmic link accounting for clustering to compare diarrhea prevalence across intervention and control groups separately for both census and monthly survey data. No intervention impact was detected in the census (vaccine only versus control: 2.32% versus 2.53%; P = 0.49; vaccine plus behavior change versus control: 2.44% versus 2.53%; P = 0.78) or in the vaccine only versus control in the monthly survey (3.39% versus 3.80%; P = 0.69). However, diarrhea prevalence was lower in the vaccine-plus-behavior-change group than control in the monthly survey (2.08% versus 3.80%; P = 0.02). Although the reasons for different observed treatment effects in the census and monthly survey data in this study are unclear, these findings emphasize the importance of assessing objective outcomes along with reported outcomes from non-blinded trials.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31162005 PMCID: PMC6609177 DOI: 10.4269/ajtmh.18-0872
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Characteristics of individuals and households across the intervention groups during the study period (October 2011–July 2013)*
| Characteristics of individuals | Vaccine-only group ( | Vaccine-plus-behavior-change group ( | Control group ( |
|---|---|---|---|
| Age, mean (SD) (years) | 22.8 (15.4) | 22.8 (15.3) | 22.8 (15.5) |
| ≤ 5 | 14.7 | 14.7 | 14.8 |
| > 5–15 | 18.3 | 17.8 | 18.5 |
| > 15–50 | 62.1 | 62.6 | 61.5 |
| > 50 | 4.9 | 4.9 | 5.2 |
| Gender (male) | 48.3 | 48.7 | 48.6 |
| Educational status | |||
| No formal education (includes children aged < 5 years) | 44.3 | 40.7 | 42.9 |
| Below primary | 17.0 | 17.0 | 17.0 |
| Primary and some secondary | 30.6 | 32.4 | 30.9 |
| Above secondary | 8.1 | 9.9 | 9.3 |
| No. of people in a family (median, interquartile range) | 5 (4–6) | 5 (3–6) | 5 (4–6) |
| No. of months living in this house (median, interquartile range) | 5 (2–36) | 6 (2–36) | 6 (3–36) |
* Unique person/household identification number; some categories do not sum to 100% because of rounding.
† Other sources of drinking water include well, bottled water, water vendor, and pond/canal/river.
‡ Latrine with piped sewer system, septic tank, pit latrine with slab plus water seal, pit latrine with slab and no water seal but with lid, ventilated improved pit latrine, dual pit latrine, or composting toilet.
Reported diarrhea prevalence within last 2 days of interview among children aged ≤ 5 years across intervention and control groups from census and monthly survey data (October 2011–July 2013)
| Groups | Diarrhea prevalence from census, % ( | Intervention vs. control groups in census,* % of difference in prevalence; 95% CI; | Diarrhea prevalence from monthly surveys, % ( | Intervention vs. control groups in monthly surveys,* % of difference in prevalence; 95% CI; |
|---|---|---|---|---|
| All study groups combined | 2.43 (6,081/250,514) (2.19, 2.69) | – | 2.87 (171/5,949) (2.26, 3.65) | – |
| Vaccine-only group | 2.32 (1,981/85,484) (1.91, 2.81) | Prevalence 0.2% lower in vaccine-only group than control; −0.0080, 0.0039; 0.49 | 3.39 (53/1,564) (2.06, 5.53) | Prevalence is 0.4% lower in vaccine-only group than control; −0.0244, 0.0162; 0.69 |
| Vaccine-plus-behavior-change group | 2.44 (2,028/83,075) (2.03, 2.94) | Prevalence 0.1% lower in vaccine-plus-behavior-change group compared to control; −0.0068, 0.0051; 0.78 | 2.08 (59/2,832) (1.39, 3.12) | Prevalence is 1.7% lower in vaccine-only group than control; −0.0320, −0.0023; 0.02 |
| Control group | 2.53 (2,072/81,955) (2.12, 3.01) | – | 3.80 (59/1,553) (2.67, 5.37) | – |
* Results are adjusted for cluster-randomized design.
Figure 1.Comparison of reported diarrhea prevalence between census and monthly surveys (along with 95% CI) for children aged ≤ 5 years across intervention and control groups during the study period. This figure appears in color at